These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5340049)

  • 41. Tiapamil dose ranging study on exercise performance in patients with exercise induced angina and coronary artery disease.
    Maltz MB; O'Keefe JC; Butrous GS; Camm AJ
    Arq Bras Cardiol; 1984 Jun; 42(6):443-6. PubMed ID: 6393922
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of the efficacy of verapamil in a slow-release preparation in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M; Antuofermo F; Rizzon P
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6765260
    [No Abstract]   [Full Text] [Related]  

  • 43. Augmentation of coronary collaterals and protection against the consequences of coronary ligation following the administration of dipyridamole.
    Schmier J; Kaden F; Schmidt HD
    Brux Med; 1970 Sep; 50(9):617-22. PubMed ID: 5510362
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 45. [The effect of magnesium ions on isolated blood vessels and their therapeutic significance in coronary spasms].
    Hoang ND; Brecht K
    Med Welt; 1981 Jun; 32(24):964-6. PubMed ID: 7253903
    [No Abstract]   [Full Text] [Related]  

  • 46. [Controlled clinical multicenter investigations. With special mention of investigation of drug treatment of angina pectoris].
    Andreasen F; Boye E
    Ugeskr Laeger; 1973 Feb; 135(7):348-50. PubMed ID: 4569634
    [No Abstract]   [Full Text] [Related]  

  • 47. [The problem of angina pectoris in the light of Persantin and Sedapersantin therapy].
    TOMEK S
    Wien Med Wochenschr; 1963 Mar; 113():234-9. PubMed ID: 13985398
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antiangina medications].
    Reuse J
    Brux Med; 1970 Sep; 50(9):553-5. PubMed ID: 5510354
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of ditrimine in angina pectoris].
    Britov AN; Arshakuni RO; Grudtsyn GV
    Kardiologiia; 1970 Nov; 10(11):92-6. PubMed ID: 5533117
    [No Abstract]   [Full Text] [Related]  

  • 51. [Changes of the coronary arteriovenous O2 difference in the man following intravenous injection of dipyridamol (Persantin)].
    Hilger HH; Wagner J; Hellwig H; Louven B; Wackerbauer J; Schaede A
    Z Kreislaufforsch; 1967 Dec; 56(12):1192-206. PubMed ID: 5593119
    [No Abstract]   [Full Text] [Related]  

  • 52. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Surgical treatment of angina pectoris and myocardial infarction--with special reference to reconstruction of blood circulation].
    Sezai Y
    Naika; 1971; 28(2):274-81. PubMed ID: 5571654
    [No Abstract]   [Full Text] [Related]  

  • 54. Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise.
    Bala Subramanian V; Lahiri A; Parmasivan R; Raftery EB
    Clin Invest Med; 1980; 3(1-2):111-8. PubMed ID: 6781805
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of digitalis preparations on the coronary veins of patients with coronary insufficiency].
    Slutskiĭ ME; Vysokiĭ FF; Khvoĭnitskaia IL
    Ter Arkh; 1966 Dec; 39(12):42-5. PubMed ID: 6012204
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypoxia and the heart ultrastructure with special reference to the protective action of the coronary drug Persantin.
    Lozada BB; Laguens RP
    Cardiologia (Basel); 1966; 49():Suppl 1:33-43. PubMed ID: 5989065
    [No Abstract]   [Full Text] [Related]  

  • 57. [CONSIDERATIONS ON TREATMENT WITH THE ASSOCIATION OF MEPROBAMATE AND PERSANTIN].
    DA FONSECA M; FERREIRA FG; DIAS FO; NUNES FC; RIOJA DO; SILVA FS
    J Med (Oporto); 1965 Feb; 56():297-302. PubMed ID: 14348582
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
    Stone PH; Muller JE; Turi ZG; Geltman E; Jaffe AS; Braunwald E
    Arq Bras Cardiol; 1983 Dec; 41(6):469-76. PubMed ID: 6431950
    [No Abstract]   [Full Text] [Related]  

  • 59. Observations made with Sensit in the treatment of angina pectoris patients.
    Keller L; Landi A
    Ther Hung; 1983; 31(4):176-80. PubMed ID: 6400457
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of the clinical electrophysiological effects of antianginal drugs without specific antiarrhythmic properties.
    Franchi F; Padeletti L
    Methods Find Exp Clin Pharmacol; 1981; 3(1):17-27. PubMed ID: 7230972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.